Hansen Ho, PharmD

Title(s)Oncology & Infusion Supervisor, COO
SchoolChancellor/EVC/FAS
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPGY2 Oncology ResidencyPharmacy
    University of Southern CaliforniaPGY1 ResidencyPharmacy
    University of California, San FranciscoPharmDPharmacy
    University of California, DavisB.S.Biochemistry and Molecular Biology
    Collapse Awards and Honors
    UCSF Department of Pharmaceutical ServicesVal Louie Award
    UCSF School of Pharmacy, Department of Clinical PharmacyGary Rifkand Spring Research Conference

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer. 2021 05; 9(5). de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. PMID: 33980590; PMCID: PMC8118032.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    2. Combination pertuzumab, trastuzumab, and taxane for metastatic breast cancer after first progression: a single institution's experience. J Oncol Pharm Pract. 2016 Apr; 22(2):261-4. Dao BD, Ho H, Quintal LN. PMID: 25802300.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Hansen's Networks
    Concepts (28)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.